Table 2.
Male | Female | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
10-14 | 15-19 | 20-24 | 10-14 | 15-19 | 20-24 | 10-14 | 15-19 | 20-24 | ||
2019/
2020 |
Primary AI | |||||||||
PAI | 6.10 | 9.12 | 6.82 | 7.72 | 4.14 | 12.01 | 6.89 | 6.70 | 9.34 | |
CAH | 0.00 | 1.30 | 2.27 | 3.86 | 5.52 | 2.40 | 1.88 | 3.35 | 2.34 | |
Secondary AI | ||||||||||
Hypopituitarism | 21.98 | 26.06 | 21.59 | 16.74 | 5.52 | 12.01 | 19.43 | 16.09 | 16.94 | |
Other AI | 18.31 | 14.33 | 1.14 | 15.45 | 5.52 | 7.21 | 16.92 | 10.05 | 4.09 | |
All SAI | 40.29 | 41.70 | 22.73 | 33.47 | 12.42 | 20.42 | 36.97 | 27.48 | 21.61 | |
AC | 10.99 | 14.33 | 7.95 | 6.44 | 16.56 | 39.65 | 8.77 | 15.42 | 23.36 | |
All AI | 57.38 | 66.46 | 39.77 | 51.50 | 38.64 | 74.49 | 54.52 | 52.95 | 56.65 | |
2000/1 | Male | Female | Total | |||||||
10-14 | 15-19 | 20-24 | 10-14 | 15-19 | 20-24 | 10-14 | 15-19 | 20-24 | ||
Primary AI | ||||||||||
PAI | 5.81 | 8.77 | 9.17 | 1.53 | 9.15 | 3.15 | 3.72 | 8.96 | 6.20 | |
CAH | 8.72 | 1.46 | 0.00 | 6.10 | 3.05 | 1.57 | 7.44 | 2.24 | 0.78 | |
Secondary AI | ||||||||||
Hypopituitarism | 29.05 | 19.00 | 3.06 | 15.25 | 7.62 | 4.72 | 22.32 | 13.43 | 3.88 | |
Other AI | 2.91 | 0.00 | 0.00 | 3.05 | 3.05 | 1.57 | 2.98 | 1.49 | 0.78 | |
All SAI | 31.96 | 19.00 | 3.06 | 18.30 | 10.67 | 6.29 | 25.30 | 14.93 | 4.65 | |
AC | 2.91 | 10.23 | 16.81 | 1.53 | 6.10 | 3.15 | 2.23 | 8.21 | 10.08 | |
All AI | 49.39 | 39.46 | 29.03 | 27.45 | 28.97 | 14.16 | 38.69 | 34.33 | 21.70 |
*Rate/million.